Why can’t Asymptomatic Patients avail of COVID Test, Court asks Govt

New Delhi: The Hon’ble Chief Justice of Delhi High Court and HMJ Prateek Jalan has issued a notice in the PIL filed by Dr. KK Aggarwal, Padma Shree Awardee and President of Heart Care Foundation of India (HCFI) against the Delhi Government’s order DHC of not allowing COVID Test of Asymptomatic Patient or Pre-symptomatic patient in Delhi. Dr Aggarwal has dubbed this order of the govt ultra vires.

Delhi Government has been asked to give its report before next date of hearing i.e. 22nd June 2020.

One more similar matter filed by Ms. Renu Goswami against the said Delhi Government was also taken up in which Mr. Siddharth Luthra, Senior Advocate appeared and argued with Dr. KK Aggarwal.

Dr KK Aggarwal, argued before the Hon’ble Court stating that mostly asymptomatic cases and pre-symptomatic cases and mild/very mild symptoms cases will increase exponentially. As per the study on COVID-19 between 5% and 80 & of people testing positive for COVID-19 may be asymptomatic.

By not allowing the asymptomatic patients and pre-symptomatic patients to undertake COVID-19 testing, it means the asymptomatic patient and pre-symptomatic patients will not get proper treatment and soon all asymptomatic patients and pre-symptomatic patients will become symptomatic patients.

As “silent spreaders”, asymptomatic carriers warrant attention as part of disease prevention and control. The testing and follow-up of asymptomatic carriers should be expanded to include people in close contact with patients with confirmed COVID-19 and asymptomatic cases, clusters of outbreaks, and key areas and populations with a high risk of infection.

The right to health is a fundamental right of the citizens and it not simply the right not to be unwell, but rather the right to be well. the right to health includes healthcare which is accessible and available for the public at large. Healthcare access is the ability to obtain healthcare services such as prevention, diagnosis, treatment, and management of diseases, illness, disorders, and other health impacting conditions.

To prevent the spread of disease is the obligation or duty of the State under Article 47 of the Constitution of India. The disease being asymptomatic also, the timely care attains significance and in such a situation to wait for the symptoms of the disease to be manifested, would amount to a failure to discharge the constitutional obligation under Article 47 of the Constitution of India.

Related Posts

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs